CID-103
CASI-CID-103-201
Phase 2 small_molecule active
Quick answer
CID-103 for Chronic Immune Thrombocytopenia is a Phase 2 program (small_molecule) at CASI Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CASI Pharmaceuticals
- Indication
- Chronic Immune Thrombocytopenia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active